...
首页> 外文期刊>Vaccine >Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
【24h】

Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.

机译:中国EIAV减毒疫苗感染性克隆的氨基酸突变导致毒力逆转。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The Chinese equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) provides a unique natural model system by which attenuated mechanism and immunological control of lentivirus replication may be studied. We analyzed the critical consensus mutations that occurred during the viral passages in vitro and in vivo for vaccine's preparation. Based on the full-length infectious clone pLGFD3 (EIAV vaccine background) and according to mutations displayed during viral attenuation, we successfully constructed an infectious clones pLG5-3-l in which gag and env genes were point-mutated by overlap PCR mutagenesis strategy. pLG5-3-l was proved to have the ability of effective replication in vitro cells culture systems by Reverse Transcriptase Assay and virion observation under electron microscopy. Results of the in vivo experiments indicated that marked differences occurred between the mutated virus and their parental virus in clinical manifestation and plasma viral replication during 6-month observation period. In contrast to asymptom of animals infected with pLGFD3-V, the mutated virus (pLG5-3-l-V) developed typical clinical progression in the corresponding experimentally infected animals. The results of the distinct differences in clinical profiles and viral dynamics before and after mutation of EIAV infectious clone will help to understand the protective mechanism of Chinese EIAV vaccine and shed light on novel HIV vaccine design..
机译:中国马传染性贫血病毒(EIAV)驴白细胞减毒疫苗(DLV)提供了一个独特的自然模型系统,通过该系统可以研究慢病毒复制的减毒机制和免疫控制。我们分析了病毒体外和体内病毒传代过程中发生的关键共有突变,以制备疫苗。基于全长感染性克隆pLGFD3(EIAV疫苗背景),并根据病毒减毒过程中显示的突变,我们成功构建了通过重叠PCR诱变策略对gag和env基因进行点突变的感染性克隆pLG5-3-l。通过反转录酶测定和在电子显微镜下观察病毒体,证明pLG5-1-3-l具有在体外细胞培养系统中有效复制的能力。体内实验的结果表明,在6个月的观察期内,突变病毒与其亲本病毒之间在临床表现和血浆病毒复制方面存在明显差异。与感染了pLGFD3-V的动物的无症状相反,突变的病毒(pLG5-3-1-V)在相应的实验感染的动物中表现出典型的临床进展。 EIAV传染性克隆突变前后的临床特征和病毒动力学的明显差异,将有助于了解中国EIAV疫苗的保护机制,并为新型HIV疫苗的设计提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号